Viridian Therapeutics, Inc.DE (VRDN) Balance sheet

Market cap

$1.5B

P/E ratio

	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	11	3	47	33	25	46	42	156	103	100	212
Total cash & short-term investments	-	11	3	47	33	25	46	42	156	103	100	212
Accounts receivable, net	1	394,000	524,000	1	0	0	-	-	-	-	-	-
Inventories	0	187,000	0	-	-	-	-	-	-	-	-	-
Total current assets	7	12	4	52	65	30	130	200	431	486	738	894
Property, plant and equipment, net	1	1	-	1	1	1	0	0	1	2	1	1
Total assets	8	13	4	52	66	30	131	204	435	490	742	899
Accounts payable	0	242,000	0	1	1	1	1	2	14	2	2	9
Total current liabilities	2	2	5	4	7	10	11	14	33	27	48	71
Long-term debt, non-current	-	-	-	-	-	-	-	-	5	20	21	-
Total liabilities	-	-	-	14	15	15	11	16	40	48	71	177
Retained earnings	-7	-17,968,000	-31	-94	-126	-168	-279	-358	-488	-726	-996	-1,338
Stockholders' equity	6	10	-0	39	51	16	120	188	395	442	672	722
Working capital				-	-	-	-	-	-	-	-	-